Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients;Morbi-mortalidad asociada a la bacteriemia primaria y relacionada con catéter en pacientes críticos

Revista Espanola de Quimioterapia

Volumn 26, Issue 1, 2013, Pages 21-29

  Olaechea, Pedro M ^a   Palomar, Mercedes ^b   Álvarez Lerma, Francisco ^c   Otal, Juan José ^d   Insausti, Josu ^e   López Pueyo, M Jesús ^f  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Catheter related bloodstream infection; Critical care unit; Morbidity; Mortality; Primary bloodstream infection

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CATHETER INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DATA BASE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY;

APACHE; BACTEREMIA; CASE-CONTROL STUDIES; CATHETER-RELATED INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; DATABASES, FACTUAL; DISEASE SUSCEPTIBILITY; FEMALE; FUNGEMIA; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK; SPAIN;

EID: 84877756767     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alvarez-Lerma F, Palomar M, Olaechea P, Otal JJ, Insausti J, Cerda E. Estudio Nacional de Vigilancia de Infección Nosocomial en Unidades de Cuidados Intensivo. Informe evolutivo de los años 2003 -2005. Med Intensiva 2007; 31:6-17.
2. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-85.
3. Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 2006; 64:16-22.
4. Garnacho-Montero J, Aldabo-Pallas T, Palomar-Martínez M, Valles J, Almirante B, Garces R, Grill F, et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med 2008; 34:2185-93.
5. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
6. Renaud B, Brun-Buisson C. Outcomes of primary and catheterrelated bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001; 163:1584-90.
7. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001; 136:229-34.
8. Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unitacquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 2006; 42:1118-26.
9. Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castanon J, Franco G, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol 2007; 28:31-5.
10. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981.
11. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-30.
12. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005; 41:1591-8.
13. Blot S, Vandewoude K, Hoste E, De Waele J, Kint K, Rosiers F, et al. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol 2003; 24:912-5.
14. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003; 29:471-5.
15. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989; 110:9-6.
16. DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. J Crit Care 2007; 22:237-44.
17. Leleu G, Aegerter P, Guidet B. Systemic candidiasis in intensive care units: A multicenter, matched-cohort study. J Crit Care 2002; 17:168-75.
18. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur J Clin Microbiol Infect Dis 2006; 25:419-425.
19. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 2007; 20:391-6.
20. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheterrelated bloodstream infections in the ICU N Engl J Med 2006; 355:2725-32.
21. Hansen S, Schwab F, Behnke M, Carsauw H, Heczko P, Klavs I, et al. National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project. J Hosp Infect 2009; 71:66-73.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
23. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-63.
24. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control 1997; 25:112-6.
25. Pittet D, Hulliger S, Auckenthaler R. Intravascular device-related infections in critically ill patients. J Chemother 1995;7 (Suppl 3):55-66.
26. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control 2003; 31:475-80.
27. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401.
28. Siempos II, Kopterides P. TsangarisI, Dimopoulou I, Armaganidis AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 2009; 37:2283-9.
29. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113:480-5.
30. Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect 2002; 8:295-309.